Glenmark receives nod from USFDA for Clindamycin Phosphate Gel USP
Glenmark receives nod from USFDA for Clindamycin Phosphate Gel USP

Glenmark receives nod from USFDA for Clindamycin Phosphate Gel USP

Chinmayee D Article rating: 5.0

The company received ANDA approval by United States Food & Drug Administration (USFDA) for Clindamycin Phosphate Gel USP 1 per cent, which is the generic version of Cleocin T 1 Gel, 1 per cent, of Pharmacia & Upjohn. 

BSE 500 companies with change in promoters holding in December 2020
BSE 500 companies with change in promoters holding in December 2020

BSE 500 companies with change in promoters holding in December 2020

Apurva Joshi Article rating: 5.0

We have considered the companies listed on BSE 500 index and have listed down the top five companies, in which, promoters have increased their stake as well as another set of the top five companies, in which, promoters have decreased their stake in the quarter ended December 2020 from September 2020. 

Sensex & Nifty make a comeback; HUDCO jumps 7 per cent, OnMobile Global gains 16 per cent, MRF tumbles
Sensex & Nifty make a comeback; HUDCO jumps 7 per cent, OnMobile Global gains 16 per cent, MRF tumbles

Sensex & Nifty make a comeback; HUDCO jumps 7 per cent, OnMobile Global gains 16 per cent, MRF tumbles

Geyatee Deshpande Article rating: 3.1

 

After taking a breather of two days, the bulls returned to dominate the domestic equity markets as Sensex gained 222.13 points or 0.43 per cent to settle at 51,531.52 levels while Nifty rose by 66.05 points or 0.43 per cent to close at 15,171.55 levels. 

Should you invest in G-Secs directly?
Should you invest in G-Secs directly?

Should you invest in G-Secs directly?

Shashikant Singh Article rating: 3.2

Retail investors look for safety, return & liquidity in their investments. Read onto find out how G-Secs score on these parameters. 

Blue Star set to widen its footprint in commercial refrigeration segment
Blue Star set to widen its footprint in commercial refrigeration segment

Blue Star set to widen its footprint in commercial refrigeration segment

Shreya Chaware Article rating: 4.7

To help a lending hand to the healthcare and pharmaceutical sectors, Blue Star Limited has announced the launch of a new range of commercial refrigeration products & solutions, which are suitable for storing vaccines. 

Ola partners with ABB India for robotics & automation solutions
Ola partners with ABB India for robotics & automation solutions

Ola partners with ABB India for robotics & automation solutions

Apurva Joshi Article rating: 4.8

Ola, which is one of the leading mobility companies in the world has selected ABB India Ltd as one of its key partners for robotics and automation solutions for its mega-factory in India that will roll out the much-anticipated Ola electric scooter.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Ganesh Pawar Article rating: 3.7

The market opened in red on February 11, 2021, overall volumes in futures & options currently stand at 4,70,74,044 contracts with a turnover of Rs. 46,51,298.26 crore.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Ganesh Pawar Article rating: 2.7

The market opened in red on February 11, 2021, overall volumes in futures & options currently stand at 4,70,74,044 contracts with a turnover of Rs. 46,51,298.26 crore.

RSS
First18411842184318441846184818491850Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR